Literature DB >> 3519441

Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.

M W Turner, C Grant, N D Seymour, B Harvey, R J Levinsky.   

Abstract

C3 fragment opsonization and chemiluminescence were assessed using two yeasts (Saccharomyces cerevisiae and Candida albicans) and two strains of bacteria (Staphylococcus aureus and Escherichia coli) following incubation with sera previously shown to be either efficient or poor in the opsonization of baker's yeast. Sera with poor function consistently fixed lower levels of C3 fragments and generated less chemiluminescence with all four organisms than sera with normal function. The differences were most marked with the two yeasts. We conclude that sera with normal complement function but manifesting a relatively common defect in the opsonization of baker's yeast have a general opsonic defect.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519441      PMCID: PMC1452645     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  The importance of antibody quality in sandwich ELISA systems. Evaluation of selected commercial reagents.

Authors:  J G Shields; M W Turner
Journal:  J Immunol Methods       Date:  1986-02-27       Impact factor: 2.303

2.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

3.  A rapid objective method for measuring the yeast opsonisation activity of serum.

Authors:  R J Levinsky; B A Harvey; S Paleja
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

4.  Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect.

Authors:  M W Turner; N D Seymour; M D Kazatchkine; J F Mowbray
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

5.  Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.

Authors:  D M Roberton; N K Dhanjal; R J Levinsky; J F Mowbray; M W Turner
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

6.  Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule.

Authors:  E J Brown; K A Joiner; R M Cole; M Berger
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

7.  Defective opsonization. A common immunity deficiency.

Authors:  J F Soothill; B A Harvey
Journal:  Arch Dis Child       Date:  1976-02       Impact factor: 3.791

8.  A quantitative method for assessing the third complement factor (C3) attached to the surface of opsonized Pseudomonas aeruginosa: interrelationship between C3 fixation, phagocytosis and complement consumption.

Authors:  W Engels; J Endert; C P Van Boven
Journal:  J Immunol Methods       Date:  1985-07-16       Impact factor: 2.303

9.  The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.

Authors:  M A Kerr; J S Falconer; A Bashey; J S Beck
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

10.  A study of C3b deposition on yeast surfaces by sera of known opsonic potential.

Authors:  M W Turner; J F Mowbray; D R Roberton
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

View more
  4 in total

1.  Neisseria meningitidis and Escherichia coli are protected from leukocyte phagocytosis by binding to erythrocyte complement receptor 1 in human blood.

Authors:  Ole-Lars Brekke; Bernt Christian Hellerud; Dorte Christiansen; Hilde Fure; Albert Castellheim; Erik Waage Nielsen; Anne Pharo; Julie Katrine Lindstad; Grethe Bergseth; Graham Leslie; John D Lambris; Petter Brandtzaeg; Tom Eirik Mollnes
Journal:  Mol Immunol       Date:  2011-08-11       Impact factor: 4.407

2.  Antibody to the outer membrane proteins is the dominant opsonic antibody in normal human serum against H. influenzae type b.

Authors:  S V Hetherington
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

3.  Recombinant form of human wild type mannan-binding lectin (MBL/A) but not its structural variant (MBL/C) promotes phagocytosis of zymosan by activating complement.

Authors:  Rema Rajagopalan; Takazvida Nyaundi; Veena P Salvi; Nenoo Rawal
Journal:  Mol Immunol       Date:  2010-06-25       Impact factor: 4.407

4.  Mannose-binding lectin 2 (MBL2) gene polymorphism in asthma and atopy among adults.

Authors:  J Aittoniemi; H Soranummi; A T Rovio; M Hurme; T Pessi; M Nieminen; J Karjalainen
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.